Log in

Senseonics Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/21/2020 12:00 AM ET)
Today's Range
Now: $0.38
50-Day Range N/A
52-Week Range
Now: $0.38
Volume1.64 million shs
Average Volume2.59 million shs
Market Capitalization$91.32 million
P/E RatioN/A
Dividend YieldN/A
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More
Senseonics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.17 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostics & Research
Previous SymbolNASDAQ:SENS



Sales & Book Value

Annual SalesN/A



Market Cap$91.32 million
Next Earnings Date11/10/2020 (Estimated)
0.00 (0.00 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Senseonics?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Senseonics

When is Senseonics' next earnings date?

Senseonics is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Senseonics

How were Senseonics' earnings last quarter?

Senseonics Holdings Inc (NYSEAMERICAN:SENS) issued its quarterly earnings data on Tuesday, June, 9th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $0.09. The firm earned $0.03 million during the quarter, compared to analyst estimates of $0.77 million.
View Senseonics' earnings history

What price target have analysts set for SENS?

8 equities research analysts have issued 1-year price targets for Senseonics' stock. Their forecasts range from $0.25 to $1.00. On average, they anticipate Senseonics' stock price to reach $0.73 in the next year. This suggests a possible upside of 93.8% from the stock's current price.
View analysts' price targets for Senseonics

Are investors shorting Senseonics?

Senseonics saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 26,560,000 shares, an increase of 13.5% from the July 30th total of 23,410,000 shares. Based on an average daily volume of 3,320,000 shares, the days-to-cover ratio is currently 8.0 days. Approximately 18.7% of the company's shares are short sold.
View Senseonics' Short Interest

Who are some of Senseonics' key competitors?

What other stocks do shareholders of Senseonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), Advanced Micro Devices (AMD), Micron Technology (MU), Sorrento Therapeutics (SRNE), Tandem Diabetes Care (TNDM), CytoDyn (CYDY), Amarin (AMRN), Nabriva Therapeutics (NBRV), TransEnterix (TRXC) and NVIDIA (NVDA).

Who are Senseonics' key executives?

Senseonics' management team includes the following people:
  • Dr. Timothy T. Goodnow, Pres, CEO & Director (Age 58, Pay $897.8k)
  • Dr. Mukul Jain, Chief Operating Officer (Age 47, Pay $572.75k)
  • Mr. Nick B. Tressler, Chief Financial Officer (Age 47)
  • Dr. Francine Ratner Kaufman, Chief Medical Officer & Director (Age 69)

What is Senseonics' stock symbol?

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Who are Senseonics' major shareholders?

Senseonics' stock is owned by a number of institutional and retail investors. Top institutional shareholders include NEA Management Company LLC (7.04%), Gilder Gagnon Howe & Co. LLC (6.54%), Charles Schwab Investment Management Inc. (0.28%), Bank of America Corp DE (0.26%), Jane Street Group LLC (0.11%) and Hudson Bay Capital Management LP (0.10%).
View institutional ownership trends for Senseonics

Which major investors are selling Senseonics stock?

SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Gilder Gagnon Howe & Co. LLC, Bank of New York Mellon Corp, Charles Schwab Investment Management Inc., and Hudson Bay Capital Management LP.
View insider buying and selling activity for Senseonics

Which major investors are buying Senseonics stock?

SENS stock was purchased by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Jane Street Group LLC, Virtu Financial LLC, and Golden State Wealth Management LLC.
View insider buying and selling activity for Senseonics

How do I buy shares of Senseonics?

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Senseonics' stock price today?

One share of SENS stock can currently be purchased for approximately $0.38.

How big of a company is Senseonics?

Senseonics has a market capitalization of $91.32 million. Senseonics employs 191 workers across the globe.

What is Senseonics' official website?

The official website for Senseonics is www.senseonics.com.

How can I contact Senseonics?

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.